An Bras Dermatol 2014 Jan-Feb;89(1):165-6
Universidade Estadual Paulista, Botucatu School of Medicine, São PauloSP, Brazil, Dermatologist, Associate Professor, Botucatu School of Medicine, Universidade Estadual Paulista (UNESP) - São Paulo, SP, Brazil.
Download full-text PDF
An Bras Dermatol 2012 Nov-Dec;87(6):939-41
University of Vale of Itajaí (Universidade do Vale do Itajai - Univali) - Itajai (SC), Brazil.
The authors report a case of Tinea nigra in an 8-year-old child, male, from Itajaí, SC, Brazil, with lesions of the macular hyperchromic type, unique, asymptomatic, localized in the right palmar area. The lesion was treated with the topical antifungal butenafine, with remission of symptoms and without recurrence at follow-up for two years. Read More
Am J Trop Med Hyg 2014 Jun;90(6):981
Department of Dermatology, University of Vale do Itajaí (Univali), Itajaí, SC, Brazil; Department of Pharmaceuticals-Biochemistry, University of Vale do Itajaí (Univali), Itajaí, SC, Brazil; Department of Dermatology, Botucatu School of Medical, Universidade Estadual Paulista "Júlio de Mesquita Filho"-São Paulo, State University (FMBUNESP), Vital Brazil Hospital, Butantan Institute, São Paulo, SP, Brazil.
A 7-year-old Caucasian female resident of the southern coast of Brazil presented dark spots on the left palm that converged to a unique macule with speckled pattern at about 1 month. The mycological exam and the fungi culture were typical of Hortaea werneckii, the agent of the superficial mycosis Tinea nigra. The patient received butenafine hydrochloride 1% for 30 days, resulting in a complete remission of the lesion. Read More
J Am Acad Dermatol 2016 Jun;74(6):e121-2
Federal University of Amazonas, Amazonas, Brazil.
J Indian Med Assoc 2001 May;99(5):274-5
Grant Medical College and GT Hospital, Mumbai.
Superficial dermatophytoses of skin are very common infections seen in clinical practice. Besides topical imidazoles, triazoles and allylamines, topical butenafine (a benzylamine derivative) is a novel agent with broad antifungal activity. One hundred and eleven patients with tinea infections were enrolled in this multicentric, randomised, single-blind non-comparative study, which involved application of butenafine (1%) cream in tinea pedis (4 weeks) and tinea cruris and tinea corporis (2 weeks) cases. Read More